Peptides for Muscle Wasting Research | GH Axis, IGF-1 & Anti-Catabolic | QSC
QSC RESEARCH COMPOUND GUIDE
GH ReleaseIGF-1 AxisAnabolicMuscle Preservation
Muscle wasting (sarcopenia, cachexia, atrophy) research requires compounds that act on GH/IGF-1 anabolic pathways, androgen receptor signalling, myostatin inhibition, and anti-catabolic mechanisms. QSC supplies the key compounds for in vitro and in vivo muscle preservation and anabolic research.
What is the primary GH axis stack for muscle wasting research?
CJC-1295 No-DAC + Ipamorelin is the most studied GHRH/GHRP combination — GHRH agonism + GHRP synergistically amplifies GH pulse amplitude. IGF-1 LR3 can be added to study direct IGF-1R signalling independently of endogenous GH.
How do BPC-157 and TB-500 relate to muscle wasting research?
BPC-157 and TB-500 are anti-catabolic/repair tools rather than anabolic. They preserve existing muscle tissue by accelerating repair of micro-tears and reducing inflammatory catabolism — relevant in models where muscle damage (not just wasting) is the phenotype.
What is the best androgen for anti-catabolic muscle research?
Nandrolone decanoate has a higher anabolic:androgenic ratio than testosterone — making it preferable for pure muscle preservation studies where androgenic side effects are a confound. Testosterone cypionate is the standard for studying androgen replacement and HPG axis effects.
What formats does QSC supply these compounds in?
Lyophilised research vials (peptides), injectable research solutions (steroids). ≥99% HPLC purity, Janoshik COA. Domestic warehouses in USA, EU, UK, Canada, and Australia.
